Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1995 Dec;63(12):4569–4575. doi: 10.1128/iai.63.12.4569-4575.1995

Mitogenicity of M5 protein extracted from Streptococcus pyogenes cells is due to streptococcal pyrogenic exotoxin C and mitogenic factor MF.

K H Schmidt 1, D Gerlach 1, L Wollweber 1, W Reichardt 1, K Mann 1, J H Ozegowski 1, B Fleischer 1
PMCID: PMC173656  PMID: 7591107

Abstract

M proteins of Streptococcus pyogenes are virulence factors which impede phagocytosis, bind to many plasma proteins, and induce formation of cross-reactive autoimmune antibodies. Recently, it has been reported that some M proteins, extracted with pepsin from streptococci (pep M), are superantigens. One of these, pep M5, was investigated in detail and was shown to stimulate human T cells bearing V beta 2, V beta 4, and V beta 8. In the present study, we extracted and purified M5 protein by different biochemical methods from two M type 5 group A streptococcal strains. The crude extracts were fractionated by affinity chromatography and ion-exchange chromatography. All fractions were tested in parallel for M protein by immunoblotting and for T-cell-stimulating activity. Although several crude preparations of M5 protein were associated with mitogenicity for V beta 2 and V beta 8 T cells, the M5 proteins, irrespective of the extraction method, could be purified to the extent that they were no longer mitogenic. The mitogenic activity was not destroyed during the purification procedures but was found in fractions separated from M protein. In these fractions, streptococcal pyrogenic exotoxin C and mitogenic factor MF could be detected by protein blotting and enzyme-linked immunosorbent assay. Moreover, anti-M protein sera did not inhibit the mitogenic activity of crude extracts, but antisera which contained anti-streptococcal pyrogenic exotoxin C antibodies showed inhibition. The inability of M5 protein to stimulate T cells was confirmed with recombinant pep M5 produced in Escherichia coli. Our data strongly suggest that the mitogenic activity in M protein preparations is caused by traces of streptococcal superantigens different from M protein.

Full Text

The Full Text of this article is available as a PDF (367.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beachey E. H., Campbell G. L., Ofek I. Peptic digestion of streptococcal M protein. II. Extraction of M antigen from group A streptococci with pepsin. Infect Immun. 1974 May;9(5):891–896. doi: 10.1128/iai.9.5.891-896.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Braun M. A., Gerlach D., Hartwig U. F., Ozegowski J. H., Romagné F., Carrel S., Köhler W., Fleischer B. Stimulation of human T cells by streptococcal "superantigen" erythrogenic toxins (scarlet fever toxins). J Immunol. 1993 Mar 15;150(6):2457–2466. [PubMed] [Google Scholar]
  3. Esaki Y., Fukui Y., Sudo T., Yamamoto K., Inamitsu T., Nishimura Y., Hirokawa K., Kimura A., Sasazuki T. Role of human major histocompatibility complex DQ molecules in superantigenicity of streptococcus-derived protein. Infect Immun. 1994 Apr;62(4):1228–1235. doi: 10.1128/iai.62.4.1228-1235.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fischetti V. A. Streptococcal M protein: molecular design and biological behavior. Clin Microbiol Rev. 1989 Jul;2(3):285–314. doi: 10.1128/cmr.2.3.285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fleischer B., Schmidt K. H., Gerlach D., Köhler W. Separation of T-cell-stimulating activity from streptococcal M protein. Infect Immun. 1992 May;60(5):1767–1770. doi: 10.1128/iai.60.5.1767-1770.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gerlach D., Günther E., Köhler W., Vettermann S., Fleischer B., Schmidt K. H. Isolation and characterization of a mitogen characteristic of group A streptococci (Streptococcus pyogenes). Zentralbl Bakteriol. 1995 Jan;282(1):67–82. [PubMed] [Google Scholar]
  7. Gerlach D., Knöll H., Köhler W., Ozegowski J. H., Hríbalova V. Isolation and characterization of erythrogenic toxins. V. Communication: identity of erythrogenic toxin type B and streptococcal proteinase precursor. Zentralbl Bakteriol Mikrobiol Hyg A. 1983 Sep;255(2-3):221–233. [PubMed] [Google Scholar]
  8. Gerlach D., Reichardt W., Fleischer B., Schmidt K. H. Separation of mitogenic and pyrogenic activities from so-called erythrogenic toxin type B (Streptococcal proteinase). Zentralbl Bakteriol. 1994 Mar;280(4):507–514. doi: 10.1016/s0934-8840(11)80510-4. [DOI] [PubMed] [Google Scholar]
  9. Horstmann R. D., Sievertsen H. J., Knobloch J., Fischetti V. A. Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H. Proc Natl Acad Sci U S A. 1988 Mar;85(5):1657–1661. doi: 10.1073/pnas.85.5.1657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Iwasaki M., Igarashi H., Hinuma Y., Yutsudo T. Cloning, characterization and overexpression of a Streptococcus pyogenes gene encoding a new type of mitogenic factor. FEBS Lett. 1993 Sep 27;331(1-2):187–192. doi: 10.1016/0014-5793(93)80323-m. [DOI] [PubMed] [Google Scholar]
  11. KANTOR F. S. FIBRINOGEN PRECIPITATION BY STREPTOCOCCAL M PROTEIN. I. IDENTITY OF THE REACTANTS, AND STOICHIOMETRY OF THE REACTION. J Exp Med. 1965 May 1;121:849–859. doi: 10.1084/jem.121.5.849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Knöll H., Kühnemund O., Havlícek J. Mitogenic and antigenic properties of group A streptococcal M protein preparations. Immunobiology. 1980 Jan;156(4-5):537–548. doi: 10.1016/S0171-2985(80)80086-6. [DOI] [PubMed] [Google Scholar]
  13. Kotb M., Majumdar G., Tomai M., Beachey E. H. Accessory cell-independent stimulation of human T cells by streptococcal M protein superantigen. J Immunol. 1990 Sep 1;145(5):1332–1336. [PubMed] [Google Scholar]
  14. Kotb M., Ohnishi H., Majumdar G., Hackett S., Bryant A., Higgins G., Stevens D. Temporal relationship of cytokine release by peripheral blood mononuclear cells stimulated by the streptococcal superantigen pep M5. Infect Immun. 1993 Apr;61(4):1194–1201. doi: 10.1128/iai.61.4.1194-1201.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kühnemund O., Havlicek J., Knöll H., Sjöquist J., Köhler W. Interaction of group A type 1 streptococcal M protein with fibrinogen. Acta Pathol Microbiol Immunol Scand B. 1985 Jun;93(3):201–209. doi: 10.1111/j.1699-0463.1985.tb02877.x. [DOI] [PubMed] [Google Scholar]
  16. LANCEFIELD R. C., PERLMANN G. E. Preparation and properties of type-specific M antigen isolated from a group A, type 1 hemolytic streptococcus. J Exp Med. 1952 Jul;96(1):71–82. doi: 10.1084/jem.96.1.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Manjula B. N., Fischetti V. A. Studies on group A streptococcal M-proteins: purification of type 5 M-protein and comparison of its amino terminal sequence with two immunologically unrelated M-protein molecules. J Immunol. 1980 Jan;124(1):261–267. [PubMed] [Google Scholar]
  18. Manjula B. N. Molecular aspects of the phagocytosis resistance of group A streptococci. Eur J Epidemiol. 1988 Sep;4(3):289–300. doi: 10.1007/BF00148912. [DOI] [PubMed] [Google Scholar]
  19. Miller L., Gray L., Beachey E., Kehoe M. Antigenic variation among group A streptococcal M proteins. Nucleotide sequence of the serotype 5 M protein gene and its relationship with genes encoding types 6 and 24 M proteins. J Biol Chem. 1988 Apr 25;263(12):5668–5673. [PubMed] [Google Scholar]
  20. Mollick J. A., Miller G. G., Musser J. M., Cook R. G., Grossman D., Rich R. R. A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C. J Clin Invest. 1993 Aug;92(2):710–719. doi: 10.1172/JCI116641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Norrby-Teglund A., Newton D., Kotb M., Holm S. E., Norgren M. Superantigenic properties of the group A streptococcal exotoxin SpeF (MF). Infect Immun. 1994 Dec;62(12):5227–5233. doi: 10.1128/iai.62.12.5227-5233.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Ozegowski J. H., Wollweber L., Schmidt K. H., Vettermann S., Reichardt W., Köhler W. Streptococcal erythrogenic toxin type C is not a phosphorylated protein. Description of two different purification procedures and investigation of its phosphorylation state. FEMS Immunol Med Microbiol. 1994 Jun;9(1):65–76. doi: 10.1111/j.1574-695X.1994.tb00475.x. [DOI] [PubMed] [Google Scholar]
  23. Reichardt W., Müller-Alouf H., Alouf J. E., Köhler W. Erythrogenic toxins A, B and C: occurrence of the genes and exotoxin formation from clinical Streptococcus pyogenes strains associated with streptococcal toxic shock-like syndrome. FEMS Microbiol Lett. 1992 Dec 15;100(1-3):313–322. doi: 10.1111/j.1574-6968.1992.tb14058.x. [DOI] [PubMed] [Google Scholar]
  24. Robinson J. H., Atherton M. C., Goodacre J. A., Pinkney M., Weightman H., Kehoe M. A. Mapping T-cell epitopes in group A streptococcal type 5 M protein. Infect Immun. 1991 Dec;59(12):4324–4331. doi: 10.1128/iai.59.12.4324-4331.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Robinson J. H., Kehoe M. A. Group A streptococcal M proteins: virulence factors and protective antigens. Immunol Today. 1992 Sep;13(9):362–367. doi: 10.1016/0167-5699(92)90173-5. [DOI] [PubMed] [Google Scholar]
  26. Romagné F., Besnardeau L., Malissen B. A versatile method to produce antibodies to human T cell receptor V beta segments: frequency determination of human V beta 2+ T cells that react with toxic-shock syndrome toxin-1. Eur J Immunol. 1992 Oct;22(10):2749–2752. doi: 10.1002/eji.1830221043. [DOI] [PubMed] [Google Scholar]
  27. STOLLERMAN G. H., KANTOR F. S., GORDON B. D. Accessory plasma factors involved in the bactericidal test for type-specific antibody to group A streptococci. I. A typical behavior of some human and rabbit bloods. J Exp Med. 1958 Oct 1;108(4):475–491. doi: 10.1084/jem.108.4.475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Schmidt K. H., Mann K., Cooney J., Köhler W. Multiple binding of type 3 streptococcal M protein to human fibrinogen, albumin and fibronectin. FEMS Immunol Med Microbiol. 1993 Aug;7(2):135–143. doi: 10.1111/j.1574-695X.1993.tb00392.x. [DOI] [PubMed] [Google Scholar]
  29. Schmidt K. H., Wadström T. A secreted receptor related to M1 protein of Streptococcus pyogenes binds to fibrinogen, IgG, and albumin. Zentralbl Bakteriol. 1990 Jun;273(2):216–228. doi: 10.1016/s0934-8840(11)80252-5. [DOI] [PubMed] [Google Scholar]
  30. Schmidt K. H., Wiesner J., Gerlach D., Reichardt W., Ozegowski J. H., Köhler W. Susceptibility of chicken embryos to group A streptococci: correlation with fibrinogen binding. FEMS Immunol Med Microbiol. 1993 Oct;7(3):231–240. doi: 10.1111/j.1574-695X.1993.tb00403.x. [DOI] [PubMed] [Google Scholar]
  31. Tomai M. A., Aelion J. A., Dockter M. E., Majumdar G., Spinella D. G., Kotb M. T cell receptor V gene usage by human T cells stimulated with the superantigen streptococcal M protein. J Exp Med. 1991 Jul 1;174(1):285–288. doi: 10.1084/jem.174.1.285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Tomai M. A., Schlievert P. M., Kotb M. Distinct T-cell receptor V beta gene usage by human T lymphocytes stimulated with the streptococcal pyrogenic exotoxins and pep M5 protein. Infect Immun. 1992 Feb;60(2):701–705. doi: 10.1128/iai.60.2.701-705.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Tomai M., Kotb M., Majumdar G., Beachey E. H. Superantigenicity of streptococcal M protein. J Exp Med. 1990 Jul 1;172(1):359–362. doi: 10.1084/jem.172.1.359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Wagner B., Schmidt K. H., Wagner M., Köhler W. Albumin bound to the surface of M protein-positive streptococci increased their phagocytosis by human polymorphonuclear leukocytes in the absence of complement and bactericidal antibodies. Zentralbl Bakteriol Mikrobiol Hyg A. 1986 Jul;261(4):432–446. doi: 10.1016/s0176-6724(86)80075-x. [DOI] [PubMed] [Google Scholar]
  35. Wang B., Schlievert P. M., Gaber A. O., Kotb M. Localization of an immunologically functional region of the streptococcal superantigen pepsin-extracted fragment of type 5 M protein. J Immunol. 1993 Aug 1;151(3):1419–1429. [PubMed] [Google Scholar]
  36. Watanabe-Ohnishi R., Aelion J., LeGros L., Tomai M. A., Sokurenko E. V., Newton D., Takahara J., Irino S., Rashed S., Kotb M. Characterization of unique human TCR V beta specificities for a family of streptococcal superantigens represented by rheumatogenic serotypes of M protein. J Immunol. 1994 Feb 15;152(4):2066–2073. [PubMed] [Google Scholar]
  37. Whitnack E., Beachey E. H. Antiopsonic activity of fibrinogen bound to M protein on the surface of group A streptococci. J Clin Invest. 1982 Apr;69(4):1042–1045. doi: 10.1172/JCI110508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Wollweber L., Fritzke H., Ozegowski J. H., Gerlach D., Köhler W. Production and partial characterization of monoclonal antibodies against erythrogenic toxins type A and C from Streptococcus pyogenes. Hybridoma. 1994 Oct;13(5):403–408. doi: 10.1089/hyb.1994.13.403. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES